256 related articles for article (PubMed ID: 15756674)
1. Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load.
Molling JW; Kölgen W; van der Vliet HJ; Boomsma MF; Kruizenga H; Smorenburg CH; Molenkamp BG; Langendijk JA; Leemans CR; von Blomberg BM; Scheper RJ; van den Eertwegh AJ
Int J Cancer; 2005 Aug; 116(1):87-93. PubMed ID: 15756674
[TBL] [Abstract][Full Text] [Related]
2. Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells.
van der Vliet HJ; Molling JW; Nishi N; Masterson AJ; Kölgen W; Porcelli SA; van den Eertwegh AJ; von Blomberg BM; Pinedo HM; Giaccone G; Scheper RJ
Cancer Res; 2003 Jul; 63(14):4101-6. PubMed ID: 12874013
[TBL] [Abstract][Full Text] [Related]
3. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
[TBL] [Abstract][Full Text] [Related]
4. Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection.
van der Vliet HJ; von Blomberg BM; Hazenberg MD; Nishi N; Otto SA; van Benthem BH; Prins M; Claessen FA; van den Eertwegh AJ; Giaccone G; Miedema F; Scheper RJ; Pinedo HM
J Immunol; 2002 Feb; 168(3):1490-5. PubMed ID: 11801694
[TBL] [Abstract][Full Text] [Related]
5. Circulating Valpha24+Vbeta11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients.
van der Vliet HJ; Molling JW; von Blomberg BM; Kölgen W; Stam AG; de Gruijl TD; Mulder CJ; Janssen HL; Nishi N; van den Eertwegh AJ; Scheper RJ; van Nieuwkerk CJ
Clin Immunol; 2005 Feb; 114(2):183-9. PubMed ID: 15639652
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity.
Nieda M; Okai M; Tazbirkova A; Lin H; Yamaura A; Ide K; Abraham R; Juji T; Macfarlane DJ; Nicol AJ
Blood; 2004 Jan; 103(2):383-9. PubMed ID: 14512316
[TBL] [Abstract][Full Text] [Related]
7. Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15.
van der Vliet HJ ; Nishi N; Koezuka Y; von Blomberg BM ; van den Eertwegh AJ ; Porcelli SA; Pinedo HM; Scheper RJ; Giaccone G
J Immunol Methods; 2001 Jan; 247(1-2):61-72. PubMed ID: 11150537
[TBL] [Abstract][Full Text] [Related]
8. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.
Giaccone G; Punt CJ; Ando Y; Ruijter R; Nishi N; Peters M; von Blomberg BM; Scheper RJ; van der Vliet HJ; van den Eertwegh AJ; Roelvink M; Beijnen J; Zwierzina H; Pinedo HM
Clin Cancer Res; 2002 Dec; 8(12):3702-9. PubMed ID: 12473579
[TBL] [Abstract][Full Text] [Related]
9. NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells.
Kenna T; Golden-Mason L; Porcelli SA; Koezuka Y; Hegarty JE; O'Farrelly C; Doherty DG
J Immunol; 2003 Aug; 171(4):1775-9. PubMed ID: 12902477
[TBL] [Abstract][Full Text] [Related]
10. Recovery of Valpha24+ NKT cells after hematopoietic stem cell transplantation.
Haraguchi K; Takahashi T; Hiruma K; Kanda Y; Tanaka Y; Ogawa S; Chiba S; Miura O; Sakamaki H; Hirai H
Bone Marrow Transplant; 2004 Oct; 34(7):595-602. PubMed ID: 15300228
[TBL] [Abstract][Full Text] [Related]
11. Frequency of Valpha24+Vbeta11+ NKT cells in peripheral blood of human kidney transplantation recipients.
Galante NZ; Ozaki KS; Cenedeze MA; Kallás EG; Salomão R; Pacheco-Silva A; Câmara NO
Int Immunopharmacol; 2005 Jan; 5(1):53-8. PubMed ID: 15589459
[TBL] [Abstract][Full Text] [Related]
12. Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes.
Gadola SD; Dulphy N; Salio M; Cerundolo V
J Immunol; 2002 Jun; 168(11):5514-20. PubMed ID: 12023346
[TBL] [Abstract][Full Text] [Related]
13. Cord blood Vα24-Vβ11 natural killer T cells display a Th2-chemokine receptor profile and cytokine responses.
Harner S; Noessner E; Nadas K; Leumann-Runge A; Schiemann M; Faber FL; Heinrich J; Krauss-Etschmann S
PLoS One; 2011 Jan; 6(1):e15714. PubMed ID: 21305060
[TBL] [Abstract][Full Text] [Related]
14. Increased intratumor Valpha24-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas.
Tachibana T; Onodera H; Tsuruyama T; Mori A; Nagayama S; Hiai H; Imamura M
Clin Cancer Res; 2005 Oct; 11(20):7322-7. PubMed ID: 16243803
[TBL] [Abstract][Full Text] [Related]
15. Natural killer T cell-mediated immunotherapy for malignant diseases.
Motohashi S; Nakayama T
Front Biosci (Schol Ed); 2009 Jun; 1(1):108-16. PubMed ID: 19482686
[TBL] [Abstract][Full Text] [Related]
16. Impairment of Vα24-Jα18
Zhao H; Li Z; Xie S; Luo Y; Zhou Y; Deng M; Zeng H; Zhao J; Yu L; Xu B
Exp Cell Res; 2019 Jan; 374(1):69-75. PubMed ID: 30439366
[TBL] [Abstract][Full Text] [Related]
17. Decreased frequency and proliferative response of invariant Valpha24Vbeta11 natural killer T (iNKT) cells in healthy elderly.
Peralbo E; DelaRosa O; Gayoso I; Pita ML; Tarazona R; Solana R
Biogerontology; 2006; 7(5-6):483-92. PubMed ID: 16953330
[TBL] [Abstract][Full Text] [Related]
18. Preserved IFN-alpha production of circulating Valpha24 NKT cells in primary lung cancer patients.
Motohashi S; Kobayashi S; Ito T; Magara KK; Mikuni O; Kamada N; Iizasa T; Nakayama T; Fujisawa T; Taniguchi M
Int J Cancer; 2002 Nov; 102(2):159-65. PubMed ID: 12385012
[TBL] [Abstract][Full Text] [Related]
19. A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer.
Motohashi S; Ishikawa A; Ishikawa E; Otsuji M; Iizasa T; Hanaoka H; Shimizu N; Horiguchi S; Okamoto Y; Fujii S; Taniguchi M; Fujisawa T; Nakayama T
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6079-86. PubMed ID: 17028247
[TBL] [Abstract][Full Text] [Related]
20. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
